"REFILL" | Peter Pitt on FDA Advisory Committees, Make America Healthy Again, and Drug Pricing (Originally Aired: May 23, 2025)

Joe Grogan sits down with Peter Pitt, FDA veteran and expert on healthcare regulation, to discuss FDA advisory committees, the Make America Healthy Again initiative, and critical gaps in pharmaceutical labeling. Pitt addresses why obesity-related drug dosing information is missing from labels, the importance of vaccine safety, food regulation reform, and strategies for lowering drug prices through generic drug reviews and supply chain diversification. He also discusses the need for FDA and CMS to work together and warns against mission creep at CMS.

Key Timestamps

0:44 Background: East Coast native, McGill University, from New York City

1:07 How he got a professorship at University of Paris School of Medicine

2:35 Mark McClellan connection and FDA career start

5:19 Conflicts of interest versus interests in FDA advisory committees

7:07 Why people need to be dismissed from advisory committees

9:13 Three basic reasons FDA holds advisory committee meetings

11:08 Why Canada keeps advisory committees secret versus FDA transparency

14:08 Advisory committees for CYA, new science, and lack of consensus

19:44 Op-ed on vaccines and nutrition under Make America Healthy Again

22:44 Cancer drug dosing for obese patients and missing label information